Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Varex Imaging (VREX) EPS (Weighted Average and Diluted) (2016 - 2026)

Varex Imaging has reported EPS (Weighted Average and Diluted) over the past 11 years, most recently at $0.05 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 600.0% to $0.05 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.63 through Jan 2026, down 34.71% year-over-year, with the annual reading at -$1.7 for FY2025, 41.67% down from the prior year.
  • EPS (Weighted Average and Diluted) was $0.05 for Q1 2026 at Varex Imaging, down from $0.3 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.67 in Q3 2023 and troughed at -$2.15 in Q3 2025.
  • The 5-year median for EPS (Weighted Average and Diluted) is $0.09 (2022), against an average of -$0.07.
  • Year-over-year, EPS (Weighted Average and Diluted) crashed 7266.67% in 2025 and then surged 600.0% in 2026.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.08 in 2022, then plummeted by 112.5% to -$0.01 in 2023, then crashed by 12500.0% to -$1.26 in 2024, then skyrocketed by 123.81% to $0.3 in 2025, then plummeted by 83.33% to $0.05 in 2026.
  • Per Business Quant, the three most recent readings for VREX's EPS (Weighted Average and Diluted) are $0.05 (Q1 2026), $0.3 (Q4 2025), and -$2.15 (Q3 2025).